The  Fourteenth Meeting of the Parties  decided in  Dec. XIV/4:      To note with appreciation the excellent work done by the Technology and Economic Assessment Panel and its Technical Options Committees;   To authorize the levels of production and consumption necessary to satisfy essential uses of CFCs for metered-dose inhalers for asthma and chronic obstructive pulmonary diseases as specified in annex I to the report of the Fourteenth Meeting of the Parties, subject to the conditions established by the Meeting of the Parties in paragraph 2 of its decision VII/28.